North American Pharmaceutical & Biotech Industry Outlook Forecasts More Than $18 Billion in 2011 Pro

Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Industrial Info Resources is pleased to announce the release of the 2011 Pharmaceutical & Biotech Industry Outlook. With the entire industry -- if not the world -- in a state of transition, the importance of having a tool that provides understanding and knowledge has never been more essential. Tap into the pulse of the North American Pharmaceutical & Biotech Industry, using a clear, concise format that demystifies this lucrative and constantly evolving industry. The 2011 Pharmaceutical & Biotech Industry outlook for capital expenditures is estimated to be $18 billion, up from the actual $9 billion in 2010 project starts. When using the 2011 Pharmaceutical & Biotech Industry Outlook, there is no need for the endless searching that often nets too much information that overwhelms rather than informs. Industrial Info has done the homework for you and packaged useful, timely and essential information and statistics into one easy-to-use format. Features include upcoming trends, vital plant and project statistics, as well as a capital and maintenance spending analysis derived from our information databases. If you will be in New York March 29-31 for the Interphex Pharmaceutical Convention, make sure to stop by Booth 1766 at the Jacob K. Javits Convention Center. We would be delighted to meet with you and give you a hands-on sample of our entire product line.